COVID-19 spike variants antigen Recombinant 2019-nCoV(SARS-CoV-2) Spike Protein S1 D614G mutant (S1-D614G,C-HisTag)

COVID-19 recombinant SARS-CoV2 (2019 nCoV coronavirus)antigen:
Recombinant 2019-nCoV(SARS-CoV-2)
Spike Protein S1 D614G mutant (S1-D614G,C-HisTag).
Suitable for variants of Spike protein & ACE2 competition binding assay for efficacy evaluation of COVID-20 vaccines and therapeutic antibodies.
Validated in functional ELISA, other immunoassays, The antigen can also be used in drug discovery including antibody screening and lead compound candidates assay.
The world is in midst of the COVID-19 pandemic caused by SARS-CoV-2 (2019nCoV) infection.The Spike protein (S-protein) of SARS-CoV-2 (2019nCoV) mediates receptor (ACE2) binding and cell entry and is the dominant target of the immune system.The D614G mutation in Spike S1 domain is proved to be a most important and popular mutant variant in Coronavirus SARS-CoV2.